Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Sales | -2,917,300 | 1,717,900 | 1,740,800 | 1,438,900 | 1,785,600 |
| Cost of Goods | -2,162,400 | 1,018,700 | 1,038,400 | 888,000 | 1,118,400 |
| Gross Profit | -754,900 | 699,200 | 702,400 | 550,900 | 667,200 |
| Operating Expenses | -696,500 | 495,400 | 509,900 | 490,400 | 988,000 |
| Operating Income | -58,800 | 204,500 | 192,900 | 60,500 | -320,400 |
| Interest Expense | -17,400 | 55,100 | 53,400 | 52,500 | 57,900 |
| Other Income | -300 | 6,900 | -9,600 | -4,500 | 8,900 |
| Pre-tax Income | -41,700 | 156,300 | 129,900 | 3,500 | -369,400 |
| Income Tax | -41,700 | 31,100 | 29,300 | -5,400 | -89,800 |
| Net Income Continuous | 0 | 125,200 | 100,600 | 8,900 | -279,600 |
| Minority Interests | 900 | 1,100 | 800 | 1,500 | 1,700 |
| Net Income | $11,500 | $124,100 | $99,800 | $7,400 | $-281,300 |
| EPS Basic Total Ops | 0.08 | 0.82 | 0.66 | 0.05 | -1.86 |
| EPS Basic Continuous Ops | 0.00 | 0.83 | 0.67 | 0.06 | -1.87 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 0.01 |
| EPS Diluted Total Ops | 0.07 | 0.82 | 0.66 | 0.05 | -1.84 |
| EPS Diluted Continuous Ops | 0.00 | 0.82 | 0.66 | 0.06 | -1.84 |
| EBITDA(a) | $3,800 | $263,800 | $251,600 | $134,600 | $-254,000 |